2010 Basic Science Mentee/Mentor Awards

MENTEEABSTRACT TITLEMENTOR
Arthur Andakyan, United States CD4CD25 Positive Mast Cells in Long-Term Surviving Grafts Followed by T-Regulatory Therapy: MC-regs? Natalya Semiletova
Sonal Asthana, Canada The Impact of Sirolimus Based Immunosuppression on Response to Anti-HCV Therapy After Liver Transplantation Norman Kneteman
Agata Bartczak, Canada FGL2 expression induces graft survival in the absence of immunosuppression. Gary Levy
Lars Burdorf, United States Pilot evaluation of anti-GP1b effects on platelet sequestration in an ex vivo xenogeneic pig liver perfusion model Richard N. Pierson III
Hong Shiue Chou, United States In Vivo Evidence: the Role of Complement Component 3 (C3) in Induction of Myeloid-Derived Suppressor Cells (MDSC) Shiguang Qian
Pietro Cippà, Switzerland Bcl-2 inhibition: a new concept to prevent solid allograft rejection Thomas Fehr
Marcella Franquesa, Spain Cell therapy using MSCs and BMDCs in rat kidney transplantation Immaculada Herrero-Fresneda
Wei Geng, China The potential role of early-phase graft injury in induction of late-phase chemoresistance after liver transplantation Chung-Mau Lo
Ines Goncalves Harper, United Kingdom A Novel Mechanism for Alloantibody Production. Gavin Pettigrew
Aleishia Harris, United States Modulation of Cellular MicroRNA by Latent Membrane Protein 1 of Epstein Barr Virus in B Cell Lymphomas Type: Oral Sessions Topic: 06. Complications / e. Malignancy Authors Olivia  Martinez
Min Hu, Australia Allograft Tolerance in Mice with MGMT Chimeric Bone Marrow Engraftment Stephen  Alexander
Yanfei Huang, United States Kidney-derived mesenchymal stem cells modulate dendritic and T cell function to inhibit alloimmune responses and prolong allograft survival Karl Womer
Fadi Issa, United Kingdom Regulatory T cell therapy prolongs human skin allograft survival in humanised mouse model Kathryn Wood
Mylvaganam Jeyakanthan, Canada  Is blood group antigen expression on vascular endothelium required for B cell tolerance induction following ABO-incompatible transplant during immunological immaturity? Lori West
Gillian Kinnear , United Kingdom Blockade of OX40 costimulation reduces the alloreactive effector T cell pool and prevents CD8+ T cell mediated skin allograft rejection. Nicholas Jones
Zhu Lan, Canada Suppression of Antidonor Antibody Response by Soluble CD83 Prevents Chronic Renal Allograft Rejection Hao Wang
Anlun Ma, Canada Contribution of regulatory T cells combined with low-dose Sirolimus, but not Tacrolimus, to delay acute rejection of renal allografts in cynomolgus monkeys Huifang Chen
Carolina  Moore, Chile Allogeneic Treg generated in vitro with retinoic acid and TGF-β control cytokine production and allograft rejection. Mario  Rosemblatt
Gerhard Mundinger, United States Chronic rejection in a non-human primate model of facial composite tissue allotransplantation: clinical, pathological, and immunohistochemical characterization Rolf Barth
Graeme O'Boyle, United Kingdom A strategy to inhibit effector T cell infiltration of allograft tissues by stimulation of the chemokine receptor CXCR3 John Kirby
Nina Pilat, Austria Administration of polyclonal recipient Tregs leads to mixed chimerism, skin and heart graft tolerance without irradiation Thomas  Wekerle
Siddharth Rajakumar, Australia CD73 deficiency and inhibition protect in kidney ischaemia reperfusion injury (IRI) Karen Dwyer
Tim Searcy, Australia Synergistic Immunomodulation by Immunosuppressive agentsand Human Mesenchymal Stem Cells on T-cell proliferation andDendritic cell maturation Ravi Krishnan
Helena Smith-Hurst, Australia A pathway for Human Islet Protease-Activated Receptors (PARs) in Tissue Factor mediated Immediate Blood Inflammatory Reaction. Philip O'Connell
Özlem Tapirdamaz, Netherlands Detailed kinetics of T-cells with direct allospecificity after liver transplantation: a novel assay Jaap Kwekkeboom
Angela Tjon, Netherlands In vivo immunosuppressive effects of intravenous immunoglobulin on innate and adaptive immune cells involved in allograft rejection Jaap Kwekkeboom
Liang Wei, United States Acute Rejection of Cardiac Allografts results in a Unique Signature of MicroRNAs Sheri Krams

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi